A Phase 1b/2 Study of Chidamide Combined with CHOP in Previously Untreated Patients with Peripheral T-Cell Lymphoma (PTCL)

被引：2
|
作者：
Shi, Yuankai [1 ]
Gui, Lin [1 ]
Cao, Junning [2 ]
Zhang, Huilai [3 ]
Zhu, Jun [4 ]
Ji, Dongmei [5 ]
Fan, Qian [3 ]
Song, Yuqin [4 ]
Shen, Weina [5 ]
Bai, Guiying [3 ]
Han, Ming-Zhe [6 ]
Jiang, Shiyu [1 ]
机构：
[1] Chinese Acad Med Sci & Peking Union Med Coll, Beijing Key Lab Clin Study Anticancer Mol Targete, Dept Med Oncol, Natl Canc Ctr,Natl Clin Res Ctr Canc,Canc Hosp, Beijing, Peoples R China
[2] Fudan Univ, Shanghai Canc Ctr, Dept Med Oncol, Shanghai Med Coll, Shanghai, Peoples R China
[3] Tianjin Med Univ Canc Inst & Hosp, Dept Lymphoma, Sino US Ctr Lymphoma & Leukemia Res, Natl Clin Res Ctr Canc,Key Lab Canc Prevent & The, Tianjin, Peoples R China
[4] Peking Univ Canc Hosp & Inst, Dept Lymphoma, Key Lab Carcinogenesis & Translat Res, Minist Educ, Beijing, Peoples R China
[5] Fudan Univ, Shanghai Canc Ctr, Dept Med Oncol, Shanghai Med Coll, Shanghai, Peoples R China
[6] Chinese Acad Med Sci, Hematopoiet Stem Cell Transplantat Ctr, Inst Hematol, Tianjin, Peoples R China
来源：
BLOOD | 2019年 / 134卷
关键词：
D O I：
10.1182/blood-2019-128078
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
2840
引用
收藏
页数：3
相关论文
共 50 条
  • [31] CHOP chemotherapy plus Campath-1H (CHOP-C) as first line treatment in patients with peripheral T-cell lymphoma (PTCL).
    Gallamini, A
    Zaja, F
    Gargantini, L
    Manna, A
    Secondo, V
    Levis, A
    Rigacci, L
    Mazza, P
    Iannitto, E
    Pinto, A
    Tucci, A
    Patti, C
    Zoli, V
    Torchio, P
    BLOOD, 2005, 106 (11) : 935A - 935A
  • [32] Safe and Effective Treatment of Patients with Peripheral T-Cell Lymphoma (PTCL) with the Novel HDAC Inhibitor, Belinostat, in Combination with CHOP: Results of the Bel-CHOP Phase 1 Trial
    Johnston, Patrick B.
    Cashen, Amanda F.
    Nikolinakos, Petros G.
    Beaven, Anne W.
    Barta, Stefan Klaus
    Bhat, Gajanan
    Song, Tao
    Choi, Mi Rim
    Allen, Lee F.
    de Vos, Sven
    Oki, Yasuhiro
    Deng, Changchun
    Foss, Francine M.
    BLOOD, 2015, 126 (23)
  • [33] Chop chemotherapy plus campath-1H (CHOP-C) as first line treatment in patients with peripheral T-cell lymphoma (PTCL)
    Gallamini, A
    Zaja, F
    Gargantini, L
    Levis, A
    Rigacci, L
    Manna, A
    Secondo, V
    Specchia, M
    Iannitto, E
    Pinto, A
    ANNALS OF ONCOLOGY, 2005, 16 : 131 - 131
  • [34] Intensive chemotherapy (high-dose CHOP/ESHAP regimen) followed by autologous stem-cell transplantation (ASCT) in previously untreated patients with peripheral T-cell lymphoma (PTCL). Results of a prospective phase II study from the GELCAB.
    Lopez-Guillermo, A
    Mercadal, S
    Briones, J
    Xicoy, B
    Pedro, C
    Escoda, L
    Estany, C
    Camos, M
    Ribera, JM
    Martino, R
    Montserrat, E
    BLOOD, 2005, 106 (11) : 587A - 588A
  • [35] PERIPHERAL T-CELL LYMPHOMA (PTCL) - A CLINICOPATHOLOGICAL STUDY OF 42 CASES
    WEISENBURGER, DD
    LINDER, J
    ARMITAGE, JO
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1986, 27 : 199 - 199
  • [36] Phase I study of vorinostat in combination with standard CHOP in patients with newly diagnosed peripheral T-cell lymphoma
    Oki, Yasuhiro
    Younes, Anas
    Copeland, Amanda
    Hagemeister, Fredrick
    Fayad, Luis E.
    McLaughlin, Peter
    Shah, Jatin
    Fowler, Nathan
    Romaguera, Jorge
    Kwak, Larry W.
    Pro, Barbara
    BRITISH JOURNAL OF HAEMATOLOGY, 2013, 162 (01) : 138 - 141
  • [37] Comparison of Chemotherapy Combined With Chidamide Versus Chemotherapy in the Frontline Treatment for Peripheral T-Cell Lymphoma
    Wang, Jinni
    Su, Ning
    Fang, Yu
    Ma, Shuyun
    Zhang, Yuchen
    Cai, Jun
    Zou, Qihua
    Tian, Xiaopeng
    Xia, Yi
    Liu, Panpan
    Li, Zhiming
    Huang, He
    Huang, Huiqiang
    Cai, Qingqing
    FRONTIERS IN IMMUNOLOGY, 2022, 13
  • [38] Baseline total metabolic tumor volume combined with international peripheral T-cell lymphoma project may improve prognostic stratification for patients with peripheral T-cell lymphoma (PTCL)
    Jiang, Chong
    Teng, Yue
    Chen, Jieyu
    Wang, Zhen
    Zhou, Zhengyang
    Ding, Chongyang
    Xu, Jingyan
    EJNMMI RESEARCH, 2020, 10 (01)
  • [39] Is the survival of patients with peripheral T-cell lymphoma (PTCL) different from patients with diffuse aggressive B-cell lymphoma (DABL)?
    Aoun, P
    Greiner, T
    Vose, J
    Gordon, B
    Kollath, J
    Bast, M
    Morris, S
    Chan, W
    Bierman, P
    Armitage, J
    Weisenburger, D
    BLOOD, 1998, 92 (10) : 84A - 84A
  • [40] Baseline total metabolic tumor volume combined with international peripheral T-cell lymphoma project may improve prognostic stratification for patients with peripheral T-cell lymphoma (PTCL)
    Chong Jiang
    Yue Teng
    Jieyu Chen
    Zhen Wang
    Zhengyang Zhou
    Chongyang Ding
    Jingyan Xu
    EJNMMI Research, 10
12345